ReviewBrain communications2026

T-cell-targeted immunotherapy in neurofibromatosis type 2-related vestibular schwannoma: current evidence and future direction.

Reygn J Done et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.